Investigative Ophthalmology & Visual Science,
Journal Year:
2025,
Volume and Issue:
66(1), P. 17 - 17
Published: Jan. 8, 2025
Purpose:
Oxidative
phosphorylation
(OXPHOS)
is
an
aerobic
metabolic
mechanism,
and
its
dysfunction
plays
important
role
in
the
pathological
changes
of
ischemic
diseases.
However,
systematic
studies
on
occurrence
retinal
detachment
(RD)
are
lacking.
Methods:
Single-cell
RNA
sequencing
(scRNA-seq)
human
retina
was
performed
to
detect
various
cells
after
RD.
In
this
study,
animal
experiments
were
conducted
explore
OXPHOS
activity
addition,
idebenone,
a
coenzyme
Q10
(CoQ10)
analog
currently
used
treat
Leber
hereditary
optic
neuropathy
(LHON),
improve
disorder
experimental
RD
model.
Results:
ScRNA-seq
revealed
abnormal
energy
metabolism
pathways
Adenosine
triphosphate
(ATP)
reactive
oxygen
species
(ROS)
main
products
OXPHOS,
mouse
model
indicated
that
rise
ROS
levels
may
have
greater
impact
photoreceptors
early
stage,
whereas
decreased
ATP
synthesis
observed
later
stage;
these
threaten
function
morphology
retina.
Idebenone
administered
mice
intragastrically,
leading
reduced
stage
post-RD
improved
which
closely
related
maintenance
mitochondrial
morphology.
Conclusions:
leads
photoreceptor
degeneration
RD,
can
be
alleviated
by
improving
function.
Frontiers in Aging Neuroscience,
Journal Year:
2024,
Volume and Issue:
16
Published: Feb. 19, 2024
Introduction
The
goal
of
this
study
is
to
explore
the
pharmacological
potential
amyloid-reducing
vasodilator
fasudil,
a
selective
Ras
homolog
(Rho)-associated
kinases
(ROCK)
inhibitor,
in
P301S
tau
transgenic
mouse
model
(Line
PS19)
neurodegenerative
tauopathy
and
Alzheimer's
disease
(AD).
Methods
We
used
LC-MS/MS,
ELISA
bioinformatic
approaches
investigate
effect
treatment
with
fasudil
on
brain
proteomic
profile
PS19
mice.
also
explored
efficacy
reducing
phosphorylation,
beneficial
and/or
toxic
effects
its
administration
Results
Proteomic
profiling
mice
brains
exposed
revealed
activation
mitochondrial
tricarboxylic
acid
(TCA)
cycle
blood-brain
barrier
(BBB)
gap
junction
metabolic
pathways.
observed
significant
negative
correlation
between
levels
phosphorylated
(pTau)
at
residue
396
both
metabolite
hydroxyfasudil.
Conclusions
Our
results
provide
evidence
proteins
pathways
related
mitochondria
BBB
functions
by
support
further
development
therapeutic
for
AD.
Antioxidants,
Journal Year:
2023,
Volume and Issue:
12(4), P. 895 - 895
Published: April 6, 2023
Stroke
is
one
of
the
leading
causes
morbidity
and
mortality
worldwide.
A
main
cause
brain
damage
by
stroke
ischemia-reperfusion
(IR)
injury
due
to
increased
production
reactive
oxygen
species
(ROS)
energy
failure
caused
changes
in
mitochondrial
metabolism.
Ischemia
a
build-up
succinate
tissues
NADH:
ubiquinone
oxidoreductase
(complex
I)
activity
that
promote
reverse
electron
transfer
(RET),
which
portion
electrons
derived
from
are
redirected
ubiquinol
along
complex
I
reach
NADH
dehydrogenase
module
I,
where
matrix
NAD+
converted
excessive
ROS
produced.
RET
has
been
shown
play
role
macrophage
activation
response
bacterial
infection,
transport
chain
reorganization
supply,
carotid
body
adaptation
levels.
In
addition
stroke,
deregulated
RET-generated
(RET-ROS)
have
implicated
tissue
during
organ
transplantation,
whereas
an
RET-induced
NAD+/NADH
ratio
decrease
aging,
age-related
neurodegeneration,
cancer.
this
review,
we
provide
historical
account
roles
oxidative
pathogenesis
ischemic
summarize
latest
developments
our
understanding
biology
RET-associated
pathological
conditions,
discuss
new
ways
target
cancer,
neurodegenerative
diseases
modulating
RET.
Biomolecules,
Journal Year:
2023,
Volume and Issue:
13(2), P. 226 - 226
Published: Jan. 24, 2023
Mitochondria
are
widely
considered
the
"power
hub"
of
cell
because
their
pivotal
roles
in
energy
metabolism
and
oxidative
phosphorylation.
However,
beyond
production
ATP,
which
is
major
source
chemical
supply
eukaryotes,
mitochondria
also
central
to
calcium
homeostasis,
reactive
oxygen
species
(ROS)
balance,
apoptosis.
The
perform
crucial
multifaceted
biosynthetic
pathways,
serving
as
an
important
building
blocks
for
biosynthesis
fatty
acid,
cholesterol,
amino
glucose,
heme.
Since
play
multiple
vital
cell,
it
not
surprising
that
disruption
mitochondrial
function
has
been
linked
a
myriad
diseases,
including
neurodegenerative
cancer,
metabolic
disorders.
In
this
review,
we
discuss
key
physiological
pathological
functions
present
bioactive
compounds
with
protective
effects
on
mechanisms
action.
We
highlight
promising
existing
difficulties
limiting
therapeutic
use
these
potential
solutions.
provide
insights
perspectives
into
future
research
windows
modulators.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 13144 - 13144
Published: Dec. 6, 2024
The
efficacy
of
assisted
reproductive
technologies
(ARTs)
in
older
women
remains
constrained,
largely
due
to
an
incomplete
understanding
the
underlying
pathophysiology.
This
review
aims
consolidate
current
knowledge
on
age-associated
mitochondrial
alterations
and
their
implications
for
ovarian
aging,
with
emphasis
causes
DNA
(mtDNA)
mutations,
repair
mechanisms,
future
therapeutic
directions.
Relevant
articles
published
up
30
September
2024
were
identified
through
a
systematic
search
electronic
databases.
free
radical
theory
proposes
that
reactive
oxygen
species
(ROS)
inflict
damage
mtDNA
impair
function
essential
ATP
generation
oocytes.
Oocytes
face
prolonged
pressure
persisting
five
decades.
MtDNA
exhibits
limited
capacity
double-strand
break
repair,
heavily
depending
poly
ADP-ribose
polymerase
1
(PARP1)-mediated
single-strand
breaks.
process
depletes
nicotinamide
adenine
dinucleotide
(NAD⁺)
ATP,
creating
detrimental
cycle
where
continued
further
compromises
oocyte
functionality.
Interventions
interrupt
this
destructive
may
offer
preventive
benefits.
In
conclusion,
cumulative
burden
mutations
demands
can
lead
depletion
elevate
risk
aneuploidy,
ultimately
contributing
ART
failure
women.
Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(22), P. 6742 - 6742
Published: Nov. 14, 2022
Alzheimer's
disease
(AD),
a
chronic
and
progressive
neurodegenerative
disease,
is
characterized
by
memory
cognitive
impairment
the
accumulation
in
brain
of
abnormal
proteins,
more
precisely
beta-amyloid
(β-amyloid
or
Aβ)
Tau
proteins.
Studies
aimed
at
researching
pharmacological
treatments
against
AD
have
focused
on
molecules
capable,
one
way
another,
preventing/eliminating
accumulations
aforementioned
Unfortunately,
than
100
years
after
discovery
there
still
no
effective
therapy
modifying
biology
behind
nipping
bud.
This
state
affairs
has
made
neuroscientists
suspicious,
so
much
that
for
several
idea
gained
ground
not
direct
neuropathological
consequence
taking
place
downstream
deposition
two
toxic
but
rather
multifactorial
including
mitochondrial
dysfunction
as
an
early
event
pathogenesis
AD,
occurring
even
before
clinical
symptoms.
reason
why
search
agents
capable
normalizing
functioning
these
subcellular
organelles
vital
importance
nerve
cells
certainly
to
be
considered
promising
approach
design
neuroprotective
drugs
preserving
this
organelle
arrest
delay
progression
disease.
Here,
our
intent
provide
updated
overview
alterations
related
disorder
therapeutic
strategies
(both
natural
synthetic)
targeting
dysfunction.